1. Home
  2. PTCT vs EPR Comparison

PTCT vs EPR Comparison

Compare PTCT & EPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

N/A

Current Price

$56.37

Market Cap

5.0B

Sector

Health Care

ML Signal

N/A

Logo EPR Properties

EPR

EPR Properties

N/A

Current Price

$58.93

Market Cap

4.5B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
PTCT
EPR
Founded
1998
1997
Country
United States
United States
Employees
N/A
54
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
4.5B
IPO Year
2006
1997

Fundamental Metrics

Financial Performance
Metric
PTCT
EPR
Price
$56.37
$58.93
Analyst Decision
Buy
Hold
Analyst Count
15
12
Target Price
★ $100.47
$64.68
AVG Volume (30 Days)
★ 939.5K
851.1K
Earning Date
10-29-2026
10-28-2026
Dividend Yield
N/A
★ 6.32%
EPS Growth
★ 264.48
105.00
EPS
0.34
★ 2.75
Revenue
$264,734,000.00
★ $718,357,000.00
Revenue This Year
N/A
$10.56
Revenue Next Year
$8.29
$5.13
P/E Ratio
$171.44
★ $21.41
Revenue Growth
★ 36.19
2.91
52 Week Low
$58.15
$48.36
52 Week High
$90.87
$64.97

Technical Indicators

Market Signals
Indicator
PTCT
EPR
Relative Strength Index (RSI) 33.38 52.81
Support Level N/A $59.09
Resistance Level $69.74 $59.46
Average True Range (ATR) 2.50 1.24
MACD -0.78 -0.11
Stochastic Oscillator 1.01 32.54

Price Performance

Historical Comparison
PTCT
EPR

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About EPR EPR Properties

EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.

Share on Social Networks: